Listen: The Unlikely Pioneer Behind mRNA Vaccines
The Daily podcast by the New York Times interviewed Dr. Katalin Kariko about the long road to getting mRNA into the vaccines that are winning the war against COVID.
Back to health care’s other big challenges: Return of the Innovation Accelerator
Check out the three selected projects for the Penn Medicine Center for Health Care Innovation's Innovation Accelerator.
NextUp: The Philly biotech company developing an in vivo approach to CAR T-Cell therapy
Interius BioTherapeutics just raised $76 million in seed funding to advance their clinical testing.
Penn’s gene therapy program has signed a 150,000 sq ft lease at a former GlaxoSmithKline property in King of Prussia
“The Penn transaction is an indicator that the entire region is benefiting from the research being done in our world-renowned institutions.”
Interius Therapeutics raises record-breaking Series A round
A two-year-old Philadelphia gene therapy company spun out of the University of Pennsylvania has raised $76 million
Rapid COVID-19 diagnostic test delivers accurate results within 4 minutes
A low-cost, rapid diagnostic test for COVID-19 developed by Penn Medicine provides COVID-19 results within four minutes with 90% accuracy.